Dendritic cell maturation (Antigen-presenting cell stimulation)

Dendritic cell maturation refers to the complex cellular process by which immature dendritic cells (DCs)—specialized antigen-capturing cells—differentiate into mature antigen-presenting cells capable of priming naïve T lymphocytes and orchestrating adaptive immune responses. This transition is triggered by exposure to pathogens (via pattern recognition receptors such as toll-like receptors), inflammatory cytokines (e.g., GM-CSF and IL‑4), microbial products like lipopolysaccharide (LPS), or signals from dying/apoptotic cells. During maturation: * DCs decrease their endocytic activity but dramatically increase expression of major histocompatibility complex class II molecules and costimulatory molecules such as CD80/B7.1, CD86/B7.2, and CD40. * They upregulate chemokine receptor CCR7 to migrate toward lymphoid tissues. * Mature DCs present processed antigens on MHC molecules to activate helper T-cells (CD4+), cytotoxic T-cells (CD8+), and B-cells. * The outcome can be either induction of immunity against pathogens/cancer or tolerance toward self-antigens depending on context/signaling cues received during the maturation phase. * Key intracellular signaling pathways involved include NF‑κB for upregulation of surface molecules required for antigen presentation/maturation; ERK pathway for survival; STAT family proteins regulate differentiation in response to cytokines. * The ability to manipulate this process underlies many immunotherapeutic strategies in cancer vaccines and autoimmunity. This entry is not a single molecular target but rather describes an essential immunological cellular program/process involving multiple molecular players.

Other names

Dendritic cell activationAntigen-presenting cell activationDC maturationAPC stimulation